Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy

Figure 6

Radar map plotting the correlation of tumor mutation burden (TMB) (a) and microsatellite instability (MSI) (b) with TDO2 expression across 33 cancer types.

(a)

(b)